Recalls / Firms / Cipla USA, Inc.
Cipla USA, Inc.
15 FDA drug recalls on record — 1 Class I.
| Date | Class | Drug | Status |
|---|---|---|---|
| 2026-02-18 | Class III | Nilotinib | Ongoing |
| 2026-02-18 | Class III | Nilotinib | Ongoing |
| 2026-01-02 | Class II | Lanreotide Acetate | Ongoing |
| 2025-12-22 | Class III | Diclofenac Sodium | Ongoing |
| 2025-11-14 | Class II | Cinacalcet | Ongoing |
| 2025-11-14 | Class II | Cinacalcet | Ongoing |
| 2025-11-14 | Class II | Cinacalcet | Ongoing |
| 2025-10-24 | Class II | Lanthanum Carbonate | Ongoing |
| 2025-10-24 | Class II | Lanthanum Carbonate | Ongoing |
| 2025-07-24 | Class III | Albuterol Sulfate | Ongoing |
| 2025-06-30 | Class II | Budesonide | Ongoing |
| 2024-10-23 | Class II | Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for C | Ongoing |
| 2024-10-23 | Class II | Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for E | Ongoing |
| 2024-03-26 | Class II | Ipratropium Bromide And Albuterol Sulfate | Terminated |
| 2023-06-27 | Class I | Albuterol Sulfate | Terminated |